Clinical Trial Update: Efficacy of Pentoxifylline and Rifaximin Combination in Pentoxifylline Refractory Clinical and Subclinical Hepatopulmonary Syndrome [NA]

View source ↗

Summary

A clinical trial update evaluating the efficacy of combining pentoxifylline and rifaximin in patients with pentoxifylline-refractory hepatopulmonary syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatopulmonary Syndrome

Drugs mentioned

• Pentoxifylline (pentoxifylline)
• Rifaximin (rifaximin)

Snippet

Sponsor: Institute of Liver and Biliary Sciences, India | Conditions: Hepatopulmonary Syndrome | NA | Status: UNKNOWN